To investigate this marker in breast cancer patient samples, first we analyzed the RNA expression of TGM2 in patients with different stages of breast cancer that showed significant increase in tumors compared to adjacent normal or other normal tissues (Figure S3). Here, TGM2 is linked to breast carcinoma.